TiumBio Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.tiumbio.com

Country

South Korea

Exchange

KOSDAQ

Founded 2016

TiumBio Co., Ltd., a drug discovery company researches and develops therapeutics for patients with unaddressed rare diseases. The company's products pipeline includes chemical entity-based drugs and biopharmaceuticals comprising NCE401, NCE403, NCE406, and NBP604. It has a collaboration agreement with Oncodesign Société Anonyme for the R&D of fibrosis drug candidates. Founded in 2016, the company is based in Seongnam-si, South Korea.

Key Stats

52-Week Range

₩3415.00₩13700.00

Beta-0.50

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.